Michael T Acurio, MD | |
2005 Landry Drive, Bossier City, LA 71111 | |
(318) 752-7850 | |
(318) 752-7855 |
Full Name | Michael T Acurio |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 38 Years |
Location | 2005 Landry Drive, Bossier City, Louisiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1982606356 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207XS0117X | Orthopaedic Surgery - Orthopaedic Surgery Of The Spine | 018909 (Louisiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Advantage Home Health Care, Inc | Coushatta, LA | Home health agency |
United Home Health Care Of Shreveport | Shreveport, LA | Home health agency |
Specialists Hospital Shreveport | Shreveport, LA | Hospital |
Willis Knighton Medical Center, Inc | Shreveport, LA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Musculoskeletal Institute Of Louisiana Llc | 0143127415 | 26 |
News Archive
Flour has been identified as the main cause of occupational asthma in France, closely followed by cleaning products.
Glioblastoma, the most common and lethal form of brain tumor in adults, is challenging to treat because the tumors rapidly become resistant to therapy. As cancer researchers are learning more about the causes of tumor cell growth and drug resistance, they are discovering molecular pathways that might lead to new targeted therapies to potentially treat this deadly cancer.
The University of Texas MD Anderson Cancer Center and Mirati Therapeutics, Inc. today announced a strategic research and development collaboration to expand the evaluation of Mirati's two investigational small molecules, potent and selective KRAS inhibitors - adagrasib (MRTX849), a G12C inhibitor in clinical development, and MRTX1133, a G12D inhibitor in preclinical development, as monotherapy and in combination with other agents - which target two of the most frequent KRAS mutations in cancer.
Dynavax Technologies Corporation today announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold for the HEPLISAVTM Investigational New Drug (IND) application in individuals with chronic kidney disease.
› Verified 4 days ago
Entity Name | Musculoskeletal Institute Of Louisiana Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1316957012 PECOS PAC ID: 0143127415 Enrollment ID: O20031215000899 |
News Archive
Flour has been identified as the main cause of occupational asthma in France, closely followed by cleaning products.
Glioblastoma, the most common and lethal form of brain tumor in adults, is challenging to treat because the tumors rapidly become resistant to therapy. As cancer researchers are learning more about the causes of tumor cell growth and drug resistance, they are discovering molecular pathways that might lead to new targeted therapies to potentially treat this deadly cancer.
The University of Texas MD Anderson Cancer Center and Mirati Therapeutics, Inc. today announced a strategic research and development collaboration to expand the evaluation of Mirati's two investigational small molecules, potent and selective KRAS inhibitors - adagrasib (MRTX849), a G12C inhibitor in clinical development, and MRTX1133, a G12D inhibitor in preclinical development, as monotherapy and in combination with other agents - which target two of the most frequent KRAS mutations in cancer.
Dynavax Technologies Corporation today announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold for the HEPLISAVTM Investigational New Drug (IND) application in individuals with chronic kidney disease.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Michael T Acurio, MD 1534 Elizabeth Ave Ste 301, Shreveport, LA 71101-4531 Ph: (318) 629-5001 | Michael T Acurio, MD 2005 Landry Drive, Bossier City, LA 71111 Ph: (318) 752-7850 |
News Archive
Flour has been identified as the main cause of occupational asthma in France, closely followed by cleaning products.
Glioblastoma, the most common and lethal form of brain tumor in adults, is challenging to treat because the tumors rapidly become resistant to therapy. As cancer researchers are learning more about the causes of tumor cell growth and drug resistance, they are discovering molecular pathways that might lead to new targeted therapies to potentially treat this deadly cancer.
The University of Texas MD Anderson Cancer Center and Mirati Therapeutics, Inc. today announced a strategic research and development collaboration to expand the evaluation of Mirati's two investigational small molecules, potent and selective KRAS inhibitors - adagrasib (MRTX849), a G12C inhibitor in clinical development, and MRTX1133, a G12D inhibitor in preclinical development, as monotherapy and in combination with other agents - which target two of the most frequent KRAS mutations in cancer.
Dynavax Technologies Corporation today announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold for the HEPLISAVTM Investigational New Drug (IND) application in individuals with chronic kidney disease.
› Verified 4 days ago
Diego A Miranda, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2449 Hospital Drive, Suite 340, Bossier City, LA 71111 Phone: 318-212-7841 Fax: 318-212-7768 | |
Dr. Vikram Chatrath, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2449 Hospital Dr Ste 200, Bossier City, LA 71111 Phone: 318-212-7841 Fax: 318-212-7846 | |
Clinton G Mcalister, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2005 Landry Drive, Bossier City, LA 71111 Phone: 318-752-7850 Fax: 318-752-7855 | |
Andrew James Moritz, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2449 Hospital Dr, Suite 200, Bossier City, LA 71111 Phone: 318-425-8701 Fax: 318-424-0376 | |
Dr. John T. Mays, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2449 Hospital Drive, Suite 200, Bossier City, LA 71111 Phone: 318-425-8701 Fax: 318-424-0376 | |
Dr. Val H. Irion, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2005 Landry Dr., Bossier City, LA 71111 Phone: 318-752-7850 Fax: 318-752-7855 |